Joseph S. Au
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population.
Journal: NPJ precision oncology
Published: June 13, 2025
Consensus Statements on Precision Oncology in the China Greater Bay Area.
Journal: JCO precision oncology
Published: June 14, 2023
miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer.
miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: April 23, 2023
EGFR mutation-guided use of afatinib, erlotinib and gefitinib for advanced non-small-cell lung cancer in Hong Kong - A cost-effectiveness analysis.
Journal: PloS one
Published: September 30, 2020
Multi-scale representation of proteomic data exhibits distinct microRNA regulatory modules in non-smoking female patients with lung adenocarcinoma.
Journal: Computers in biology and medicine
Published: April 18, 2018
Joint effects of environmental exposures and familial susceptibility to lung cancer in Chinese never smoking men and women.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 24, 2014
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 15, 2014
Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer.
Journal: Oncology reports
Published: February 16, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026